| 中文名 | CA-4948 |
|---|---|
| 英文名 | CA-4948 |
| 中文别名 |
6'-氨基-N- [2-(4-吗啉基)唑并[4,5-b]吡啶-6-基] [2,3'-联吡啶] -6-甲酰胺
6'-氨基-N-[2-(吗啉-4-基)-[1,3]恶唑并[4,5-B]吡啶-6-基]-[2,3'-联吡啶]-6-甲酰胺 6'-氨基-N- [2-(4-吗啉基)唑并[4,5-b]吡啶-6-基] [2,3'-联吡啶] -6-甲酰胺 |
| 英文别名 |
IRAK4-IN-2
6'-Amino-N-[2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl][2,3'-bipyridine]-6-cboxamide IRAK4-IN-7, 10 mM in DMSO CA4948-Analog IRAK4-IN-7 ABC-type,lge B cell lymphoma,IRAK4,IRAK,lymphoma,DLBCL,IRAK4 IN 7,IL-1R associated kinase,non-Hodgkin,diffuse,IRAK-4-IN-7,Interleukin-1 rector associated kinase,Inhibitor,IRAK4IN7,inhibit IRAK4-IN-7 CA-4948 CA 4948;CA [2,3'-Bipyridine]-6-cboxamide, 6'-amino-N-[2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl] 6'-Amino-N-[2-(morpholin-4-yl)-[1,3]oxazolo[4,5-b]pyridin-6-yl]-[2,3'-bipyridine]-6-cboxamide IRAK4-IN-7 (CA4948 analog) 6'-Amino-N-(2-morpholinooxazolo[4,5-b]pyridin-6-yl)-[2,3'-bipyridine]-6-cboxamide CA 4948, CA-4948, CA4948 N-(1-(6'-amino-[2,3'-bipyridin]-5-yl)vinyl)-2-morpholinooxazolo[4,5-c]pyridin-6-amine |
| 描述 | CA-4948 是一种有选择性且有效的 IRAK4 抑制剂。 |
|---|---|
| 相关类别 | |
| 靶点 |
IRAK4[1] |
| 体内研究 | CA-4948是一种选择性和有效的IRAK4抑制剂,可用作具有失调的TLR/MYD88/IRAK4信号传导的血液癌症的治疗剂。 CA-4948表现出有利的DMPK特性,口服生物利用度,并且在小鼠中具有良好的耐受性。此外,先前显示CA-4948在ABC-DLBCL MYD88-L265P异种移植肿瘤模型中显示出剂量依赖性功效[1]。 |
| 参考文献 |
| 分子式 | C21H19N7O3 |
|---|---|
| 分子量 | 417.42 |
| 外观性状 | 粉末 |
| 储存条件 | -20℃ |